Gollob Jared
Kymera Therapeutics, Inc. · Chief Medical Officer
Gollob Jared is listed in filings as Chief Medical Officer at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR). The current snapshot covers public activity from Jul 16, 2024 to Mar 4, 2026. Reported amounts are shown as $214.2K to $41.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $214k2.5k shares | SellMar 4, 2026 | $85.04 | $113.99 | |
| $123k1.4k shares | SellMar 4, 2026 | $85.78 | $113.99 | |
| $41k492 shares | SellMar 4, 2026 | $84.00 | $113.99 | |
| $39k447 shares | SellMar 4, 2026 | $86.62 | $113.99 |